On March 5, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, announced his resignation, citing a desire to spend more time with family.
“I get home late Friday, work on weekends, and come back to Washington on Sunday. I did the job 100 percent,” Dr. Gottlieb said in an interview with The Washington Post. “It was a very hard decision. This is the best job I will ever have.”
The resignation came as a surprise to many officials. Dr. Gottlieb, a physician and venture capitalist, has held the position of FDA commissioner since 2017 and has prioritized the approval of generic drugs to lower drug prices and tackling public health issues like opioid addiction and youth vaping during his tenure.
Norman “Ned” Sharpless, MD, the current director of the National Cancer Institute, will serve as acting commissioner of the FDA as the agency searchers for a permanent replacement for Dr. Gottlieb.